A61K 49/08
Characterised by the carrier
Official title: characterised by the carrier
A61K49/08 (Characterised by the carrier) appears on 1,437 US grants and 1,998 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,437
- Published applications
- 1,998
- Assignees
- 895
- Inventors
- 4,020
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 7 | 0 |
| 1990 | 7 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 14 | 0 |
| 1994 | 15 | 0 |
| 1995 | 24 | 0 |
| 1996 | 28 | 0 |
| 1997 | 48 | 0 |
| 1998 | 30 | 0 |
| 1999 | 30 | 0 |
| 2000 | 31 | 0 |
| 2001 | 21 | 6 |
| 2002 | 21 | 40 |
| 2003 | 30 | 57 |
| 2004 | 22 | 50 |
| 2005 | 25 | 60 |
| 2006 | 22 | 63 |
| 2007 | 19 | 57 |
| 2008 | 25 | 59 |
| 2009 | 9 | 76 |
| 2010 | 23 | 91 |
| 2011 | 26 | 110 |
| 2012 | 46 | 79 |
| 2013 | 53 | 95 |
| 2014 | 77 | 122 |
| 2015 | 71 | 102 |
| 2016 | 71 | 124 |
| 2017 | 89 | 102 |
| 2018 | 70 | 76 |
| 2019 | 73 | 96 |
| 2020 | 78 | 122 |
| 2021 | 69 | 88 |
| 2022 | 59 | 73 |
| 2023 | 53 | 71 |
| 2024 | 43 | 71 |
| 2025 | 47 | 65 |
| 2026 | 35 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Single-polymer particles, active molecular complex, method for producing single-polymer particles, method for measuring tumor size, method for measuring fine structure within tumor, method for imaging biological tissue, drug delivery system, and contrast agent kit6 Oct 2026US 12,752,022 B2National Institutes for Quantum Science and Technology
- Peptide libraries with non-canonical amino acids6 Oct 2026US 12,753,205 B2Regeneron Pharmaceuticals, Inc.
- Manganese-enhanced magnetic resonance imaging29 Sep 2026US 12,745,921 B2Ic Targets AS
- Radiofrequency amplification by stimulated emission of radiation via parahydrogen induced polarization29 Sep 2026US 12,746,297 B2Wayne State University
- MRI contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels15 Sep 2026US 12,734,256 B2Lipid Systems Sp. Z O.O.
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Modular platform for molecular conjugation8 Oct 2026US 2026/0306645 A1CamBrixBio Ltd
- Pharmaceutical compositions of gd-based contrast agents8 Oct 2026US 2026/0306679 A1Bracco Imaging S.P.A.
- Compositions and method for diagnosing and treating alzheimer's disease1 Oct 2026US 2026/0294328 A1The Regents of the University of California
- Use of acrylic acid-containing polymers for molecular imaging of target proteins17 Sep 2026US 2026/0273108 A1
Most cited
By later US patents
- Diagnostic media413US 4,647,447 ASchering Corporation · 1987
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Composition useful for in vivo delivery of biologics and methods employing same369US 5,498,421 AVivorx Pharmaceuticals, Inc. · 1996
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988
- Polymeric treatment compositions330US 9,655,989 B2MicroVention, Inc. · 2017